Josephine van Dongen

Chapter 2 40 30. Vissing NH, Chawes BL, Rasmussen MA, Bisgaard H. Epidemiology and risk factors of infection in early childhood. Pediatrics. 2018;141(6). doi:10.1542/peds.2017-0933 31. Edelstein M, Merk H, Deogan C, Carnahan A, Wallensten A. Quantifying the incidence and cost of acute gastrointestinal illness in Sweden, 2013–2014. Epidemiol Infect. 2016;(144):2831-2839. doi:10.1017/S0950268816000467 32. Dornbusch HJ,VesikariT, Guarino A, LoVecchio A, Hadjipanayis A, Koletzko B. Rotavirus vaccination for all children or subgroups only? Comment of the EuropeanAcademy of Paediatrics (EAP) and the European Society for Paediatric Infectious Diseases (ESPID) recommendation group for rotavirus vaccination. Eur J Pediatr. 2020;179(9):1489-1493. doi:10.1007/s00431- 020-03608-5 33. Verberk JDM, Pijnacker R, Bruijning-Verhagen P, et al. Biennial Pattern of Rotavirus Gastroenteritis in The Netherlands and a Shifting Age Distribution Following a Low Rotavirus Season, 2010-2016 AbbreviatedTitle: Biennial Rotavirus Pattern inThe Netherlands in Absence of RotavirusVaccination Running Head: Pediatr Infect Dis J. Published online 2017. doi:10.1097/ INF.0000000000001880 34. Hahné S, Hooiveld M, Vennema H, et al. Exceptionally low rotavirus incidence in the Netherlands in 2013/14 in the absence of rotavirus vaccination. Euro Surveill Eur Commun Dis Bul l. Published online 2014. 35. Solastie A, Leino T, Ollgren J. Success of rotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness. Vaccine . 2020;38(21):3766-3772. doi:10.1016/j.vaccine.2020.03.022 36. Panozzo CA, Becker-Dreps S, PateV, et al. Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured us children, 2007-2010. Am J Epidemiol. Published online 2014. doi:10.1093/aje/kwu001 37. Mukaka M, White SA, Terlouw DJ, Mwapasa V, Kalilani-Phiri L, Faragher EB. Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing? Trials. 2016;17(1):1-12. doi:10.1186/s13063-016-1473-3 38. Donders ART, van der Heijden GJMG, Stijnen T, Moons KGM. Review: A gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087-1091. doi:10.1016/J.JCLINEPI.2006.01.014 39. Madley-Dowd P, Hughes R, Tilling K, Heron J. The propor tion of missing data should not be used to guide decisions on multiple imputation. J Clin Epidemiol. 2019;110:63-73. doi:10.1016/j.jclinepi.2019.02.016 40. Kleinbaum D, Klein M. Survival Analysis - A Self-Learning Text. 2012;(Third Edition).